In patients with advanced triple negative breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan ...

DEWALT, a Stanley Black & Decker brand and relentless innovator for jobsite professionals, today announced in collaboration ...

HOUSTON, JANUARY 22, 2026 ― A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center , published today in ...

Scientists have now developed a DNA blood test that can predict how well patients with breast cancer will respond to ...

Next-generation therapeutic vaccines company also welcomes industry veteran Eric Halioua to board, as executive chairman Lead candidate ErVac01 is a cancer vaccine targeting novel tumor antigens ...

Airbyte, creator of the open data movement platform, today announced it has joined the Linux Foundation's newly formed Agentic AI Foundation (AAIF) as a Silver Member, reinforcing its commitment to ...

A new DNA blood test may help doctors predict how breast cancer patients will respond to treatment before therapy starts, allowing more personalised and effective care. Keep reading for details.

By targeting proteins used to splice genes, UC San Diego researchers have unlocked a new approach to treating triple-negative ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced The New England Journal of Medicine (NEJM) published the full results from the positive Phase 3 ASCENT-04/KEYNOTE-D19 study evaluating the ...

James Van Der Beek took to social media to share images of his life four months after missing the Dawson's Creek reunion.

Researchers at the new campus coming to the former Bull Run coal plant in Clinton will test how materials react under intense ...

World / The Canadian prime minister offered a radical analysis of the collapse of the liberal world order. His response to ...